Does Implementing an Enhanced Recovery After Surgery Protocol Increase Hospital Charges? Comparisons From a Radical Cystectomy Program at a Specialty Cancer Center.
OBJECTIVE
To compare perioperative charges induced at the initial phase of a standardized enhanced recovery after surgery (ERAS) program from a tertiary referral center.


METHODS
A multidisciplinary ERAS protocol was implemented in our department on July 2015. During the subsequent year, all patients were treated according to this protocol (ERAS group). The patients were compared in terms of real in-hospital charges per surgical episode with a control group consisting of consecutive patients before the start of ERAS. Individual charges were analyzed per sample population and compared with the Wilcoxon rank-sum test or t test. Additionally, cost variances for each group were evaluated.


RESULTS
A total of 257 consecutive patients were evaluated of which the last 112 were ERAS patients. The median length of stay for each group was 6 days (P = .748). ERAS patients incurred higher medication charges ($1939 vs $1729, P = .036). Control patients incurred higher supplies ($861 vs $692), treatment ($90 vs $72), and miscellaneous charges ($537 vs $388) (all, P < .001). The median total charges per patient were $59,539 for the control group and $60,655 for the ERAS group (P = .175). ERAS adoption significantly reduced variance in billed charges (P < .001).


CONCLUSIONS
ERAS implementation did not significantly increase expenditure for cystectomy patients. ERAS showed decreased variance in charges likely due to standardization of care while eliciting savings in supplies, treatment, and miscellaneous costs.
Department of Genitourinary Oncology, Moffitt Cancer Center, Tampa, FL.
Juan
J
Chipollini
Department of Genitourinary Oncology, Moffitt Cancer Center, Tampa, FL.
Dominic H
DH
Tang
Morsani College of Medicine, University of South Florida, Tampa, FL.
Karim
K
Hussein
Department of Anesthesiology, Moffitt Cancer Center, Tampa, FL.
Sephalie Y
SY
Patel
Department of Anesthesiology, Moffitt Cancer Center, Tampa, FL.
Rosemarie E
RE
Garcia-Getting
Department of Genitourinary Oncology, Moffitt Cancer Center, Tampa, FL.
Julio M
JM
Pow-Sang
Department of Genitourinary Oncology, Moffitt Cancer Center, Tampa, FL.
Scott M
SM
Gilbert
Department of Genitourinary Oncology, Moffitt Cancer Center, Tampa, FL.
Wade J
WJ
Sexton
Department of Genitourinary Oncology, Moffitt Cancer Center, Tampa, FL.
Philippe E
PE
Spiess
Department of Genitourinary Oncology, Moffitt Cancer Center, Tampa, FL. Electronic address: michael.poch@moffitt.org.
Michael A
MA
Poch
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002173:Cancer Care Facilities; D002985:Clinical Protocols; D065187:Controlled Before-After Studies; D015653:Cystectomy / Q000191:economics*; D005260:Female; D017722:Hospital Charges; D006801:Humans; D007902:Length of Stay / Q000191:economics; D008297:Male; D008875:Middle Aged; D019990:Perioperative Care / Q000191:economics*; D020127:Recovery of Function; D012189:Retrospective Studies; D062606:Tertiary Care Centers; D001749:Urinary Bladder Neoplasms / Q000191:economics / Q000601:surgery*